Human Health

Cancer Research

Understanding cancer

Cancers are an incredibly complex array of disease states, resulting largely from a series of mutations that enable cells to multiply and resist the body’s defenses against unchecked cell proliferation.

Understanding the genomic, transcriptomic, and metabolomic changes that occur in cancerous cells is key to developing potential therapeutics. Eremid™ has the experience and expertise to support your cancer research efforts with a suite of state-of-the-art next-generation sequencing (target exome sequencing, single cell sequencing) and metabolomics platforms (metabolic assessment of tumor microenvironment or the patient, therapeutic response or prognosis).

Our scientists can help you design cancer research studies, as well as analyze and interpret your data.

Looking for deeper insights on your next project?

Discuss a project
Looking for deeper insights on your next project? Discuss a project
"Working with Eremid has been a pleasure. We received excellent data with a very fast turnaround and appreciated the attentive and helpful project management!" Steve Watkins, BCD Biosciences, CA USA — CEO